KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Work In Process (2017 - 2023)

Historic Work In Process for Biolife Solutions (BLFS) over the last 8 years, with Q1 2023 value amounting to $6.9 million.

  • Biolife Solutions' Work In Process rose 3854.15% to $6.9 million in Q1 2023 from the same period last year, while for Mar 2023 it was $6.9 million, marking a year-over-year increase of 3854.15%. This contributed to the annual value of $5.7 million for FY2022, which is 1326.02% up from last year.
  • Biolife Solutions' Work In Process amounted to $6.9 million in Q1 2023, which was up 3854.15% from $5.7 million recorded in Q4 2022.
  • In the past 5 years, Biolife Solutions' Work In Process registered a high of $6.9 million during Q1 2023, and its lowest value of $275000.0 during Q2 2019.
  • Its 5-year average for Work In Process is $3.3 million, with a median of $3.2 million in 2020.
  • In the last 5 years, Biolife Solutions' Work In Process crashed by 5054.44% in 2019 and then surged by 51018.18% in 2020.
  • Biolife Solutions' Work In Process (Quarter) stood at $1.9 million in 2019, then increased by 5.8% to $2.0 million in 2020, then surged by 150.0% to $5.0 million in 2021, then increased by 13.26% to $5.7 million in 2022, then increased by 22.08% to $6.9 million in 2023.
  • Its Work In Process was $6.9 million in Q1 2023, compared to $5.7 million in Q4 2022 and $5.5 million in Q3 2022.